Anti-NMDA receptor encephalitis overview: Difference between revisions
Jump to navigation
Jump to search
Created page with "==Home== ==Overview== ==Historical Perspective== ==Classification== ==Pathophysiology== ==Causes== ==Differentiating Anti-NMDA receptor encephalitis from other Diseases=..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Anti-NMDA receptor encephalitis}} | |||
{{CMG}} | |||
==Home== | ==Home== | ||
| Line 59: | Line 63: | ||
===Case #1=== | ===Case #1=== | ||
==References== | |||
{{Reflist|2}} | |||
[[Category:Needs content]] | |||
[[Category:Rheumatology]] | |||
[[Category:Disease]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 16:16, 30 June 2016
|
Anti-NMDA receptor encephalitis Microchapters |
|
Differentiating Anti-NMDA receptor encephalitis from Other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Anti-NMDA receptor encephalitis overview On the Web |
|
American Roentgen Ray Society Images of Anti-NMDA receptor encephalitis overview |
|
Directions to Hospitals Treating Anti-NMDA receptor encephalitis |
|
Risk calculators and risk factors for Anti-NMDA receptor encephalitis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]